Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Ophthalmology 9

Ophthalmology

pharma-news-for-edwards-lineage-novartis-koios-medical

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Edwards’ Sapien 3 with Alterra Prestent; Koios Medical’s breast, thyroid cancer-spotting AI; Lineage Collaborates with Genentech; Novartis, BeiGene ink deal

Edwards secures FDA approval for Sapien 3 with Alterra Prestent for Transcatheter Pulmonic Valve Replacement Edwards Lifesciences declared to receive approval from the U.S. Food and Drug Administration (FDA) to use the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for severe pulmonary regurgitation patients. The Edwards SAPIEN 3 Transcatheter Pulmonary Valve (TPV) system combines the proven SAPIEN 3 transcatheter heart valve and the Alterra adaptive prestent to extend transcatheter therapy options for congenital heart valves disease patients. The Alterra prestent makes up for variations in size and morphology of ...

Explore More...

astellas

Commercial Outcomes – Novartis

allergic conjunctivitis

Allergic Conjunctivitis (AC)- Market Insights, Epidemiology and Market Forecast- 2027

Default Blog Image

Allergic Conjunctivitis (AC) – Common disorder with increasing prevalence

BioGen

Business Cocktail

Retinal Degeneration

Retinal Degeneration : The Current Pipeline Scenario

Snippet

Wet AMD: A chronic eye condition with promising therapies

Medical tourism in India

Clinigen and Eisai team up; Sanofi, Lonza enter; Fidia to acquire; J&J completes acquisition

Prosecutors rope Pfizer; Pharma groups to FDA; Regeneron simulates; Otsuka & Lundbeck revive;Philidor execs plead

Therapeutics

PMV Raises; Argos Shares Plummet; Cidara Flunks in; Sarepta Sells to Gilead; Novartis and NHS Ayrshire & Arran launch

USFDA warns; Vit B3 prevents glaucoma; Zydus Cadila receives nod; U.S. experts soften on DNA editing

U.K. weighs drug rationing; Applying Digital; FDA slaps Florida

anterior uveitis market

Anterior Uveitis: A Vision-threatening condition

Novartis eyes; Pfizer considers cashing; Mylan pushes to seal $465M; Valeant with Takeda for deal

Bayer Partners with DelSiTech to Develop; Amgen and Arrowhead Announce; Allergan, AstraZeneca’s deal; Lexicon Pharma announces deal

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly